We are live on ! Find out more
PSP

Pacific Sage Partners Portfolio holdings

AUM $705M Turnover 13.53%
1-Year Est. Return 12.18%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+12.18%
3 Year Est. Return
+47.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$338M
AUM Growth
+$26.9M
Cap. Flow
+$9.03M
Cap. Flow %
2.67%
Top 10 Hldgs %
76.65%
Holding
97
New
9
Increased
29
Reduced
20
Closed
7
Avg Time Held
0.4 years
Top 10 Avg Time Held
0.4 years
Top 20 Avg Time Held
0.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.35%
2 Technology 25.92%
3 Consumer Discretionary 4.3%
4 Industrials 2.08%
5 Healthcare 1.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TMUS icon
76
T-Mobile US
TMUS
$171B
$226K 0.07%
1,624
– –
2022 Q4
2 quarters
JPST icon
77
JPMorgan Ultra-Short Income ETF
JPST
$42.4B
$218K 0.06%
4,350
+33
+0.8% +$1.66K
2022 Q4
2 quarters
PEP icon
78
PepsiCo
PEP
$179B
$213K 0.06%
1,150
+2
+0.2% +$373
2022 Q4
2 quarters
PI icon
79
Impinj
PI
$5.36B
$212K 0.06%
2,360
– –
2022 Q4
2 quarters
SRE icon
80
Sempra
SRE
$54.5B
$208K 0.06%
2,864
– –
2022 Q4
2 quarters
BMY icon
81
Bristol-Myers Squibb
BMY
$122B
$207K 0.06%
3,230
-575
-15% -$38.6K
2022 Q4
2 quarters
REGN icon
82
Regeneron Pharmaceuticals
REGN
$81.4B
$204K 0.06%
284
– –
2022 Q4
2 quarters
EPD icon
83
Enterprise Products Partners
EPD
$79.5B
$203K 0.06%
+7,715
New +$202K
2023 Q2
0 quarters
JWN icon
84
DELISTED
Nordstrom
JWN
$202K 0.06%
+9,869
New +$166K
2023 Q2
0 quarters
IBM icon
85
IBM
IBM
$219B
$201K 0.06%
+1,499
New +$193K
2023 Q2
0 quarters
DBO icon
86
Invesco DB Oil Fund
DBO
$313M
$192K 0.06%
13,588
– –
2022 Q4
2 quarters
CRESY icon
87
Cresud
CRESY
$817M
$78.1K 0.02%
10,287
-918
-8% -$6K
2022 Q4
2 quarters
KEEL icon
88
Keel Infrastructure Corp
KEEL
$1.43B
$73.5K 0.02%
50,000
– –
2022 Q4
2 quarters
GGN icon
89
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$822M
$65K 0.02%
17,371
+1
+0% +$4
2022 Q4
2 quarters
LUMN icon
90
Lumen Technologies, Inc. Common Stock
LUMN
$4.8B
$59.5K 0.02%
26,348
+10,506
+66% +$23.1K
2023 Q1
1 quarter
ABBV icon
91
AbbVie
ABBV
$504B
– –
-1,284
Closed -$205K –
CVS icon
92
CVS Health
CVS
$118B
– –
-2,813
Closed -$209K –
B icon
93
Barrick Mining
B
$67.2B
– –
-10,273
Closed -$191K –
SPEU icon
94
State Street SPDR Portfolio Europe ETF
SPEU
$701M
– –
-136,689
Closed -$5.2M –
XLF icon
95
State Street Financial Select Sector SPDR ETF
XLF
$51.6B
– –
-130,125
Closed -$4.18M –
ASXC icon
96
DELISTED
Asensus Surgical, Inc.
ASXC
– –
-32,665
Closed -$21.5K –
INFI
97
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-20,000
Closed -$3.2K –

Similar funds

Pacific Sage Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Pacific Sage Partners held 97 positions worth $338M, up 8.7% from $311M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Pacific Sage Partners's Q2 2023 filing shows 9 new, 29 increased, 20 reduced and 7 closed positions. Its largest new stake was Day Hagan/Ned Davis Research Smart Sector ETF: 146,165 shares worth $5.19M. The largest sale was State Street SPDR Portfolio Europe ETF, an estimated $5.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Pacific Sage Partners's largest Q2 2023 buy was Day Hagan/Ned Davis Research Smart Sector ETF: 146,165 shares worth $5.19M.
  • Pacific Sage Partners added most to iShares 3-7 Year Treasury Bond ETF in Q2 2023, an estimated $6.74M increase.
  • Pacific Sage Partners's biggest Q2 2023 reduction was Microsoft, cutting an estimated $2.3M.
  • Pacific Sage Partners fully exited State Street SPDR Portfolio Europe ETF in Q2 2023, selling an estimated $5.2M.
  • Pacific Sage Partners's ten largest holdings make up 77% of its $338M portfolio in Q2 2023.
  • Pacific Sage Partners opened 9 new positions and closed 7 in Q2 2023.
  • Pacific Sage Partners's portfolio value rose 8.7% quarter-over-quarter to $338M.

Based on Pacific Sage Partners's 13F filing for Q2 2023, filed 20 Jul 2023.